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Two biologically active molecular forms of somatos-
tatin (SRIH), derived from a common 116amino acids precu-
rsor have been characterized, the tetradecapeptide somato-
statin-14 and the C-terminally extended form somatostatin-
28 (Lewin and Romancer 1996). In the central nervous
system SRIH acts as a neurotransmitter and/or neuromo-
dulator and influences locomotor activity,cognitive functions
and behavioral processes (E pel b a u m 1986). Both peptides
are also present in non-neuronal tissues such as the gastro-
intestinal tract and endocrine tissues including the pancreas,
thyroid and adrenal gland (Reichlin 1983). Somatostatin
inhibits the secretion of several non-pituitary hormones such
as insulin, glucagon, gastrin, secretin and aldosterone (E p e 1-
ba um 1986; Mi lo s e vi c 1999). It is well known that SRIH
inhibits release of growth hormone (GH) from somato-
tropes via separate receptors in the plasma membrane (R e-
i chi i n 1983). Hypothalamic SRIH also inhibits the secre-
tion of thyrotropin-stimulating hormone (TSH) and prolactin
(PRL) from the anterior pituitary (E pel b a um et at. 1994).
The effects of SRIH on PRL cells has not been systematically
studied. There is the evidence that at pituitary level, SRIH
inhibits prolactin secretion, but at the hypothalamic level it
may increase prolactin secretion possibly by reducing dopa-
mine release (G i Iii e s 1997). This study was designed to
evaluate the effects of intracerebroventricular (i.c.v.) ad-
ministration of low doses of SRIH-14 and SRIH-28 on the
morphology and secretory activity of PRL cells in pituitary
glands of female rats.
The study was performed on adult female Wistar rats
(210-230 g). The rats were implanted with a headset later used
for i.c.v. injections. A minimum recovery time of 5 days was
permitted before the onset of experiments. The animals were
divided into three experimental groups each consisting offive
animals. The first and the second group consisted of rats given
(i.c.v.) every second day three 1-/lg doses of SRIH-14 or
SRIH-28 dissolved in 5 ul, saline. The third group was the
control treated in the same manner, except that the animals
received i.c.v. 5 ul. of saline. All animals were sacrificed by
decapitation during deep anaesthesia 5 days after the last
injection. Pituitary glands were excised, fixed in Bouin's solu-
tion and embedded in paraffin. Serial 5/lm thick tissue sec-
tions were deparaffinized. Pituitary PRL cells were localized
by the peroxidase-antiperoxidase-complex (PAP) method of
S t ern b erg e r etal. (1970). Measurements were performed
on the widest portion of the pituitary gland and immuno-
cytochemically-labelled PRL cells were analyzed by the M42
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test system after Wei bel (1979). For the calculations of the
cell and nuclear volumes the formula of Wei bel (1979) was
used. Serum concentrations of PRL in control and experime-
ntal rats were measured hy the Delfia method. Biochemical
and morphometric data obtained from each group were ave-
raged, and the standard deviation of the mean was calculated.
A one-way analysis of variance (ANOVA), followed by the
multiple range test of Dun can was used for statistical
comparisons between the groups. A probability value of 5%
or less was considered statistically significant.
Immunocytochemically labeled PRL cells in the con-
trol pituitaries were polygonal, elongated in shape, with a
spherical centrally located nucleus. PRL cells were usually
surrounded by large oval gonadotropic cells. These cellswere
sparse in the anterior-ventral portion of the gland. In i.c.v.
SRIH-treated female rats PRL cells were smaller, irregularly
shaped, with more intensely black secretory granules. All
morphometric parameters were decreased (p<0.05) in com-
parison with the control (Table 1). Serum PRL level in both
SRIH-14- and SRIH-28-treated females was significantly
decreased (p<0.05) by 85%, as compared to the control
(Fig. 1).
Tahle 1. MOI'phometric parameters of the pituitary PUL
cells after iutracerehroventricular administration of SRIH-
14 or SRIH-28 to female rats.
Experimental Volume of the Volume of the Volume density ofPRL PRL thePRLgroup
cells (rnm") rnuclei (mm'') cells(%)
Control 770 ± 24.0 148± 13.4 30 ± 1.3
SRIF-14 6.30 ± 0.1' 102 ± 10.4' 17 ± 0.7'
(-18%) (-31%) (-43%)
SRIF-28 655 ± 2.8 115 ± 5.6' 19 ± 1.4'
(-15%) (-22%) (-37%)
(means ± SD; n = 5); 'p<0.05, in comparison with the control.
These changes were similar to those obtained in male
rats treated in the same manner with SRIH-14 or SRIH-28
(M i los e vic et at. 1998). PRL cells are acidophils as GH
cells and PRL could be an ancestral molecule for GH (P a -
n tic 1990). A number of reports describe transformation of
GH cells into PRL cells as well as somatomammotropes and
mammosomatotropes (Takahashi 1992).
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In summary, intermittent exposure of female rats to
i.c.v. SRIH-14 or SRIH-28 reduces serum PRL concentra-
cions with the corresponding changes in morphology of PRL
cells that secrete these hormones.
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Fig. 1. Serum concentration of PRL after intracerebroventricular
administration ofSRIH-14 ofSRIH-28 to adult female rats. Data are
expressed as the means ± SD. (n=5), * p<O.05 in comparison with
the control.
